SC 13D/A

SCHEDULE 13D/A (AMENDMENT NO. 2)

Company: KalVista Pharmaceuticals, Inc.
Filed: February 26, 2019
Accession Number: 0001193125-19-050840

View Document ↗ View on SEC.gov ↗